BioCorRx (BICX) Goodwill (2025 - 2026)
BioCorRx's (BICX) quarterly Goodwill came in at $563158.0 in Q1 2026, down 80.17% year-on-year from $2.8 million in Q1 2025, and little changed quarter-over-quarter from $563158.0 in Q4 2025.
BioCorRx (BICX) Goodwill (2025 - 2026) Analysis & Trends
BioCorRx has disclosed Goodwill across 2 years of filings, most recently posting $563158.0 for Q1 2026.
- Goodwill for Q1 2026 came in at $563158.0, down 80.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $563158.0 (down 80.17% YoY), and the FY2025 annual result was $563158.0, changed N/A from the prior year.
- Goodwill came in at $563158.0 for Q1 2026 at BioCorRx, roughly flat from $563158.0 in the prior quarter.
- In the past five years, Goodwill ranged from a high of $2.8 million in Q1 2025 to a low of $563158.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 563,158.00 |
| Dec 31, 2025 | 563,158.00 |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 2.84 Mn |
| Mar 31, 2025 | 2.84 Mn |